Compare · CRWD vs SNCE
CRWD vs SNCE
Side-by-side comparison of CrowdStrike Holdings Inc. (CRWD) and Science 37 Holdings Inc. (SNCE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CRWD and SNCE operate in Computer Software: Prepackaged Software (Technology), so they compete in similar markets.
- CRWD is the larger of the two at $170.80B, about 185.4x SNCE ($921.1M).
- CRWD has hit the wire 39 times in the past 4 weeks while SNCE has been quiet.
- CRWD has more recent analyst coverage (25 ratings vs 5 for SNCE).
- Company
- CrowdStrike Holdings Inc.
- Science 37 Holdings Inc.
- Price
- $664.12-7.66%
- $5.75+0.17%
- Market cap
- $170.80B
- $921.1M
- 1M return
- +43.28%
- -
- 1Y return
- +44.51%
- -
- Industry
- Computer Software: Prepackaged Software
- Computer Software: Prepackaged Software
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- 2020
- News (4w)
- 39
- 0
- Recent ratings
- 25
- 5
CrowdStrike Holdings Inc.
CrowdStrike Holdings, Inc. provides cloud-delivered solutions for endpoint and cloud workload protection in the United States, Australia, Germany, India, Israel, Romania, and the United Kingdom. It offers 19 cloud modules on its Falcon platform through a software as a service subscription-based model that covers various security markets, such as corporate workload security, security and vulnerability management, managed security services, IT operations management, threat intelligence services, identity protection, and log management. The company primarily sells its platform and cloud modules through its direct sales team. CrowdStrike Holdings, Inc. was incorporated in 2011 and is headquartered in Sunnyvale, California.
Latest CRWD
- PRESIDENT AND CEO Kurtz George sold $868,977 worth of shares (1,220 units at $712.28), decreasing direct ownership by 0.06% to 2,137,022 units (SEC Form 4)
- PRESIDENT AND CEO Kurtz George sold $2,760,328 worth of shares (3,780 units at $730.25), decreasing direct ownership by 0.18% to 2,138,242 units (SEC Form 4)
- SEC Form 144 filed by CrowdStrike Holdings Inc.
- SEC Form 144 filed by CrowdStrike Holdings Inc.
- CrowdStrike downgraded by Berenberg with a new price target
- BMO Capital Markets reiterated coverage on CrowdStrike with a new price target
- Needham reiterated coverage on CrowdStrike with a new price target
- SEC Form 10-Q filed by CrowdStrike Holdings Inc.
- Director Gandhi Sameer K sold $1,404,909 worth of shares (1,809 units at $776.62) as part of a pre-agreed trading plan (SEC Form 4)
- PRESIDENT AND CEO Kurtz George sold $1,460,829 worth of shares (1,916 units at $762.44), decreasing direct ownership by 0.09% to 2,142,022 units (SEC Form 4)
Latest SNCE
- Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial
- Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research
- Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial
- Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation
- Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial
- Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
- Science 37 Enrolls 42% of Trial Cohort in 8 Weeks
- Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
- Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance